Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02108249 · ClinicalTrials.gov registry record

Annex™ Adjacent Level System for Treatment of Adjacent Level Disease

A clinical trial of Degenerative Disc Disease and Adjacent Level Disease, sponsored by Spine Wave.

Completed
Registry status
35
Enrollment target
1
Study location

NCT02108249: Completed study of Degenerative Disc Disease and Adjacent Level Disease, sponsored by Spine Wave.

NCT02108249 is a study of Degenerative Disc Disease and Adjacent Level Disease that has completed, run by Spine Wave. The registered enrollment target is 35 participants, below the 168-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02108249, a study of Degenerative Disc Disease and Adjacent Level Disease, has completed, sponsored by Spine Wave.

COMPLETED
Registry status
35 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the clinical, radiological, and surgical outcomes of the Annex™ Adjacent Level System for the treatment of adjacent level disease of the lumbar spine. The Annex™ Adjacent Level System is a spinal fixation system intended to be used with commercially available pedicle screw fixation systems in order to extend existing pedicle screw constructs. Subjects will be evaluated over a 2 year period and compared to historical control.

Interventions

  • DEVICE Annex™ Adjacent Level System

Study Locations (1)

North Carolina

  • Carolinas Neurosurgery and Spine - Charlotte

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2014-04
Est. Completion 2019-12
Spine Wave

2 total trials

What the finished NCT02108249 record still lists

NCT02108249 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 168-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (79% lower).

The record links to 2 conditions, with Degenerative Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which Annex™ Adjacent Level System is the first listed.

NCT02108249 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT02108249 about?

NCT02108249 is a clinical study titled "Annex™ Adjacent Level System for Treatment of Adjacent Level Disease". The purpose of this study is to evaluate the clinical, radiological, and surgical outcomes of the Annex™ Adjacent Level System for the treatment of adjacent level disease of the lumbar spine. The Annex™ Adjacent Level System is a spinal fixation system intended to be used with commercially available...

What is the current status of trial NCT02108249?

This trial is currently completed. The enrollment target is 35 participants. The study started on 2014-04. Estimated completion is 2019-12.

What conditions does trial NCT02108249 study?

This clinical trial studies the following conditions: Degenerative Disc Disease, Adjacent Level Disease.

What interventions are being tested in trial NCT02108249?

The interventions under investigation include: Annex™ Adjacent Level System (DEVICE).

Who is sponsoring clinical trial NCT02108249?

This trial is sponsored by Spine Wave, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02108249 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Degenerative Disc Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02108249's enrollment target sits among peer trials

35 36th of 42 higher than 6 of 42 other Degenerative Disc Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Degenerative Disc Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01697371 · 35 participants · NA

    Proton Therapy in the Treatment of Liver Metastases

  • NCT01940757 · 35 participants · Phase 1

    Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae

  • NCT02235857 · 35 participants · NA

    Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • NCT02637934 · 35 participants · Phase 1

    Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02108249, the US trial registry maintained by the National Library of Medicine. NCT02108249 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.